Rotator Cuff Tears of the ShoulderShoulder Adhesive CapsulitisShoulder Arthroscopy
Investigational drug(s) / intervention(s)
ArthroscopyDrugs administration
Arthroscopy: Early Surgical Intervention in Patients with Partial Rotator Cuff Tears and Concomitant Shoulder Stiffness.
Drugs administration: Oral Medication for Conservative Management of Partial Rotator Cuff Tears with Concomitant Shoulder Stiffness.
Study summary
A Randomized Controlled Trial Comparing Early Surgical Intervention Versus a Structured Rehabilitation Program with Delayed Surgery if Needed for Partial-Thickness Rotator Cuff Tears with Concomitant Shoulder Stiffness: The SPIRIT Trial (Surgery for Partial Tears with Immobility Randomized Intervention Trial)
Eligibility
Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria:
1. Age 18-80 years.
2. Symptomatic shoulder pain for \>2 weeks.
3. MRI-confirmed partial-thickness rotator cuff tear (\>50% tendon thickness or \>5mm in length).
4. Concomitant shoulder stiffness, defined as passive range of motion loss of ≥25% in at least two planes (forward flexion, abduction, external rotation, or internal rotation) compared to the contralateral side.
5. Failure of a brief (≥2 weeks) trial of conservative care (e.g., oral NSAIDs).
Exclusion Criteria:
1. Age\< 18 or \>80 years.
2. Full-thickness rotator cuff tear.
3. Previous surgery on the affected shoulder.
4. Glenohumeral osteoarthritis (Grade ≥2 Samilson-Prieto).
5. Cervical radiculopathy as a primary cause of symptoms.
6. Systemic inflammatory arthritis.
7. Neurologic disorder affecting the shoulder.
8. Contraindications to surgery or general anesthesia.
9. Inability to comply with the rehabilitation protocol.
Primary outcome measure(s)
Shoulder Pain and Disability Index (SPADI) — 6 month before surgery and 6 months after surgery Shoulder Pain and Disability Index (SPADI) from 0-100. The lower the number, the better the functional outcomes of the patients.
Trial sites (1)
Facility
City
Region
Status
Jialiang Guo
Shijiazhuang
Hebei
More Hebei Medical University Third Hospital trials in China
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.